loading

Telomir Pharmaceuticals Inc (TELO) 最新ニュース

pulisher
Jan 10, 2026

Is Telomir Pharmaceuticals Inc. stock a top momentum playJuly 2025 Summary & Growth Focused Entry Point Reports - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Published on: 2026-01-10 12:17:57 - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Aug Movers: Why Telomir Pharmaceuticals Inc. stock is recommended by analystsGlobal Markets & Real-Time Market Trend Scan - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Is Telomir Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Outlook & Advanced Swing Trade Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Why retail investors favor Telomir Pharmaceuticals Inc. stockQuarterly Portfolio Summary & AI Forecast for Swing Trade Picks - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Trend Review: Why retail investors favor Telomir Pharmaceuticals Inc stockEarnings Growth Report & Step-by-Step Trade Execution Guides - moha.gov.vn

Jan 08, 2026
pulisher
Jan 08, 2026

Can Telomir Pharmaceuticals Inc. stock sustain revenue growthMerger & Acquisition Updates & Build Wealth With Expert Timing Advice - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models - The Florida Times-Union

Jan 07, 2026
pulisher
Jan 07, 2026

How Telomir Pharmaceuticals Inc. stock reacts to inflationary pressuresLow Risk Investment Ideas & Minimal Investment Portfolio Growth - ulpravda.ru

Jan 07, 2026
pulisher
Jan 06, 2026

Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It - Benzinga

Jan 06, 2026
pulisher
Jan 05, 2026

Telomir Pharmaceuticals reports preclinical results for Telomir-1 in TNBC models - Investing.com Nigeria

Jan 05, 2026
pulisher
Jan 05, 2026

Telomir Highlights Positive Preclinical Results for Telomir-1 in TNBC - TipRanks

Jan 05, 2026
pulisher
Jan 05, 2026

Telomir Pharmaceuticals Reports Positive Preclinical Results for Telomir-1 - TradingView — Track All Markets

Jan 05, 2026
pulisher
Jan 05, 2026

Experimental breast cancer drug slows aggressive tumors in animal tests - Stock Titan

Jan 05, 2026
pulisher
Jan 01, 2026

Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationOptions Trading Strategies & Start Investing With Free Smart Watchlists - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Telomir Pharmaceuticals reports preclinical results for Telomir-1 in TNBC models By Investing.com - Investing.com Nigeria

Jan 01, 2026
pulisher
Dec 31, 2025

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development - Lancaster Eagle-Gazette

Dec 31, 2025
pulisher
Dec 30, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 8.9%Here's What Happened - MarketBeat

Dec 30, 2025
pulisher
Dec 30, 2025

Telomir Pharmaceuticals (NASDAQ:TELO) Shares Down 8.9% – Here’s What Happened - Defense World

Dec 30, 2025
pulisher
Dec 29, 2025

Is Telomir Pharmaceuticals Inc stock oversold or undervaluedRisk Management & Weekly Hot Stock Watchlists - moha.gov.vn

Dec 29, 2025
pulisher
Dec 26, 2025

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 26, 2025
pulisher
Dec 26, 2025

Telomir Pharmaceuticals announces Telomir-1 reverses calcium dysregulation in multiple human cell lines - MSN

Dec 26, 2025
pulisher
Dec 22, 2025

Momentum Shift: What is the fair value of Telomir Pharmaceuticals Inc stock nowPortfolio Profit Report & AI Driven Stock Movement Reports - moha.gov.vn

Dec 22, 2025
pulisher
Dec 22, 2025

Telomir Pharmaceuticals sets CEO incentive awards and salary adjustment - Investing.com

Dec 22, 2025
pulisher
Dec 20, 2025

Chipmakers Recap: Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationQuarterly Market Summary & Accurate Technical Buy Alerts - ulpravda.ru

Dec 20, 2025
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
大文字化:     |  ボリューム (24 時間):